Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.431NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.431NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.168NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.168NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.168NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Q.6 (Alpha)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
Q.6 (Alpha)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Q.6 (Alpha)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
AZ.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AZ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AZ.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.97NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.97NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.97NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.32NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.32NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.59NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.59NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.59NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.67NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-17944.4US
B.1.177.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.67NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16604.2China
B.1.277NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1269.64US
B.1.277NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
AY.28 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.28 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.28 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.272NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.272NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.272NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.371NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
B.1.1.371NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.371NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
AA.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.353NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.353NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.353NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.407NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.407NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.407NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AA.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AA.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used